Cognitive effects of dopaminergic and glutamatergic blockade in nucleus accumbens in pigeons

dc.contributor.authorGargiulo, Pascual Ángeldeu
dc.contributor.authorAcerbo, Martin Javierdeu
dc.contributor.authorKrug, Ines
dc.contributor.authorDelius, Juan
dc.date.accessioned2012-11-09T10:23:58Zdeu
dc.date.available2012-11-09T10:23:58Zdeu
dc.date.issued2005-08
dc.description.abstractIn earlier studies it was found that glutamatergic transmission within the nucleus accumbens septi is involved in the performance of a learned visual shape discrimination in pigeons. This study examines what effects several kinds of glutamate and dopamine antagonists have on the same task. Pigeons were trained with the relevant discrimination, bilaterally implanted with cannulas into the nucleus accumbens and tested after various transmission blockers had been administered intracerebrally. SCH-23390, a D1 dopamine antagonist, at the dose used, had no effect, and Spiperone, a D2-dopamine and 5HT2a-serotonine antagonist, significantly decreased the error repeat trials. CNQX, a non-NMDA glutamate receptor antagonist, and Cycloleucine, an antagonist of the glycine allosteric site of NMDA receptors, had no effect. CGS-19755, a selective competitive NMDA antagonist, significantly impaired performance by significantly decreasing the percent correct trials and increasing the error repeat trials. CPPG, a II/III metabotropic glutamate antagonist, remarkably improved performance. MMPG, a III/II metabotropic glutamate antagonist, at the dose used, did not have any significant effect. The preparation employed may be a useful animal model of perceptual disturbances in schizophrenia.eng
dc.description.versionpublished
dc.identifier.citationPharmacology Biochemistry and Behavior ; 81 (2005), 4. - S. 732-739deu
dc.identifier.doi10.1016/j.pbb.2005.05.009deu
dc.identifier.pmid15979133
dc.identifier.ppn373482167deu
dc.identifier.urihttp://kops.uni-konstanz.de/handle/123456789/20619
dc.language.isoengdeu
dc.legacy.dateIssued2012-11-09deu
dc.rightsterms-of-usedeu
dc.rights.urihttps://rightsstatements.org/page/InC/1.0/deu
dc.subjectPigeondeu
dc.subjectnucleus accumbensdeu
dc.subjectperceptiondeu
dc.subjectlearned discriminationdeu
dc.subjectglutamate antagonistsdeu
dc.subjectdopamine antagonistsdeu
dc.subjectschizophreniadeu
dc.subject.ddc150deu
dc.titleCognitive effects of dopaminergic and glutamatergic blockade in nucleus accumbens in pigeonseng
dc.typeJOURNAL_ARTICLEdeu
dspace.entity.typePublication
kops.citation.bibtex
@article{Gargiulo2005-08Cogni-20619,
  year={2005},
  doi={10.1016/j.pbb.2005.05.009},
  title={Cognitive effects of dopaminergic and glutamatergic blockade in nucleus accumbens in pigeons},
  number={4},
  volume={81},
  issn={0091-3057},
  journal={Pharmacology Biochemistry and Behavior},
  pages={732--739},
  author={Gargiulo, Pascual Ángel and Acerbo, Martin Javier and Krug, Ines and Delius, Juan}
}
kops.citation.iso690GARGIULO, Pascual Ángel, Martin Javier ACERBO, Ines KRUG, Juan DELIUS, 2005. Cognitive effects of dopaminergic and glutamatergic blockade in nucleus accumbens in pigeons. In: Pharmacology Biochemistry and Behavior. 2005, 81(4), pp. 732-739. ISSN 0091-3057. eISSN 1873-5177. Available under: doi: 10.1016/j.pbb.2005.05.009deu
kops.citation.iso690GARGIULO, Pascual Ángel, Martin Javier ACERBO, Ines KRUG, Juan DELIUS, 2005. Cognitive effects of dopaminergic and glutamatergic blockade in nucleus accumbens in pigeons. In: Pharmacology Biochemistry and Behavior. 2005, 81(4), pp. 732-739. ISSN 0091-3057. eISSN 1873-5177. Available under: doi: 10.1016/j.pbb.2005.05.009eng
kops.citation.rdf
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/20619">
    <dc:language>eng</dc:language>
    <dcterms:issued>2005-08</dcterms:issued>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-11-09T10:23:58Z</dcterms:available>
    <dc:creator>Delius, Juan</dc:creator>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-11-09T10:23:58Z</dc:date>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/43"/>
    <dc:contributor>Krug, Ines</dc:contributor>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:creator>Krug, Ines</dc:creator>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/20619/2/Delius%20Cognitive%20effects%20of%20dopaminergic%20206193.pdf"/>
    <dc:contributor>Gargiulo, Pascual Ángel</dc:contributor>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/20619/2/Delius%20Cognitive%20effects%20of%20dopaminergic%20206193.pdf"/>
    <dcterms:abstract xml:lang="eng">In earlier studies it was found that glutamatergic transmission within the nucleus accumbens septi is involved in the performance of a learned visual shape discrimination in pigeons. This study examines what effects several kinds of glutamate and dopamine antagonists have on the same task. Pigeons were trained with the relevant discrimination, bilaterally implanted with cannulas into the nucleus accumbens and tested after various transmission blockers had been administered intracerebrally. SCH-23390, a D1 dopamine antagonist, at the dose used, had no effect, and Spiperone, a D2-dopamine and 5HT2a-serotonine antagonist, significantly decreased the error repeat trials. CNQX, a non-NMDA glutamate receptor antagonist, and Cycloleucine, an antagonist of the glycine allosteric site of NMDA receptors, had no effect. CGS-19755, a selective competitive NMDA antagonist, significantly impaired performance by significantly decreasing the percent correct trials and increasing the error repeat trials. CPPG, a II/III metabotropic glutamate antagonist, remarkably improved performance. MMPG, a III/II metabotropic glutamate antagonist, at the dose used, did not have any significant effect. The preparation employed may be a useful animal model of perceptual disturbances in schizophrenia.</dcterms:abstract>
    <dc:contributor>Delius, Juan</dc:contributor>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:creator>Acerbo, Martin Javier</dc:creator>
    <dc:rights>terms-of-use</dc:rights>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dcterms:title>Cognitive effects of dopaminergic and glutamatergic blockade in nucleus accumbens in pigeons</dcterms:title>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/43"/>
    <dcterms:bibliographicCitation>Pharmacology Biochemistry and Behavior ; 81 (2005), 4. - S. 732-739</dcterms:bibliographicCitation>
    <dc:creator>Gargiulo, Pascual Ángel</dc:creator>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/20619"/>
    <dc:contributor>Acerbo, Martin Javier</dc:contributor>
  </rdf:Description>
</rdf:RDF>
kops.description.openAccessopenaccessgreen
kops.identifier.nbnurn:nbn:de:bsz:352-206193deu
kops.sourcefieldPharmacology Biochemistry and Behavior. 2005, <b>81</b>(4), pp. 732-739. ISSN 0091-3057. eISSN 1873-5177. Available under: doi: 10.1016/j.pbb.2005.05.009deu
kops.sourcefield.plainPharmacology Biochemistry and Behavior. 2005, 81(4), pp. 732-739. ISSN 0091-3057. eISSN 1873-5177. Available under: doi: 10.1016/j.pbb.2005.05.009deu
kops.sourcefield.plainPharmacology Biochemistry and Behavior. 2005, 81(4), pp. 732-739. ISSN 0091-3057. eISSN 1873-5177. Available under: doi: 10.1016/j.pbb.2005.05.009eng
kops.submitter.emailoleg.kozlov@uni-konstanz.dedeu
relation.isAuthorOfPublicatione9ac8888-0c4a-4929-931f-34e25c9d1f0e
relation.isAuthorOfPublication098ae2b0-2b77-4a36-91e3-397a0f964faa
relation.isAuthorOfPublication.latestForDiscoverye9ac8888-0c4a-4929-931f-34e25c9d1f0e
source.bibliographicInfo.fromPage732
source.bibliographicInfo.issue4
source.bibliographicInfo.toPage739
source.bibliographicInfo.volume81
source.identifier.eissn1873-5177deu
source.identifier.issn0091-3057
source.periodicalTitlePharmacology Biochemistry and Behavior

Dateien

Originalbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild nicht verfügbar
Name:
Delius Cognitive effects of dopaminergic 206193.pdf
Größe:
4.23 MB
Format:
Adobe Portable Document Format

Lizenzbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild nicht verfügbar
Name:
license.txt
Größe:
1.92 KB
Format:
Plain Text
Beschreibung:
license.txt
license.txtGröße: 1.92 KBDownloads: 0